Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Capital Expenditures (2020 - 2025)

Pulse Biosciences has reported Capital Expenditures over the past 6 years, most recently at $105000.0 for Q4 2025.

  • Quarterly results put Capital Expenditures at $105000.0 for Q4 2025, up 328.26% from a year ago — trailing twelve months through Dec 2025 was $315000.0 (up 1111.54% YoY), and the annual figure for FY2025 was $315000.0, up 1111.54%.
  • Capital Expenditures for Q4 2025 was $105000.0 at Pulse Biosciences, down from $186000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for PLSE hit a ceiling of $271000.0 in Q2 2022 and a floor of -$276000.0 in Q4 2021.
  • Median Capital Expenditures over the past 5 years was $41000.0 (2022), compared with a mean of $46842.1.
  • Biggest five-year swings in Capital Expenditures: crashed 206.98% in 2024 and later skyrocketed 328.26% in 2025.
  • Pulse Biosciences' Capital Expenditures stood at -$276000.0 in 2021, then surged by 114.86% to $41000.0 in 2022, then grew by 4.88% to $43000.0 in 2023, then crashed by 206.98% to -$46000.0 in 2024, then skyrocketed by 328.26% to $105000.0 in 2025.
  • The last three reported values for Capital Expenditures were $105000.0 (Q4 2025), $186000.0 (Q3 2025), and -$2000.0 (Q2 2025) per Business Quant data.